Trial Profile
A Randomized, Open Label, 2-way Crossover Study to Compare the Oral Bioavailability of 2 Solid Dose Formulations of GLPG0259 After Single-dose Intake in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Dec 2012
Price :
$35
*
At a glance
- Drugs GLPG 0259 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Galapagos NV
- 30 Mar 2011 New trial record